Hengsai Biological
Guangdong
About Hengsai Biological
Hengsai Bio is a tumor immunotherapy developer that engages in R&D and industrialisation of a new generation dendritic cell tumor vaccines.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $14.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Jan 2024)
- Website: kousai.vip
Industries & Categories
Biotechnology, Health Care, Medical
Canonical: https://fsome.com/organization/hengsai-biological-28924 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.